Retroperitoneal hematoma in a hemodialysis patient receiving low molecular weight heparin

Israel Medical Association Journal

Volumn 7, Issue 9, 2005, Pages 611-612

  Kruzel Davila, Etty ^a   Frajewicki, Victor ^a   Kushnir, Daniel ^a   Eyal, Abraham ^a  

^a CARMEL MEDICAL CENTER   (Israel)

Author keywords

Bleeding; Chronic kidney disease; Hemodialysis; Low molecular weight heparin; Retroperitoneal hematoma

Indexed keywords

ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; ENOXAPARIN; HEMOGLOBIN; LOW MOLECULAR WEIGHT HEPARIN; METHYLPREDNISOLONE;

AGED; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ENTEROBACTER INFECTION; FEMALE; HEMODIALYSIS; HUMAN; ILIAC VEIN; KIDNEY BIOPSY; KIDNEY FUNCTION TEST; NOTE; PERITONEAL DIALYSIS; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RETROPERITONEAL HEMATOMA; SEPSIS; VEIN THROMBOSIS;

AGED; ANTICOAGULANTS; ENOXAPARIN; FEMALE; HEMATOMA; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 24944440885     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (5)

1. Buller HR. Treatment of symptomatic venous thromboembolism: improving outcomes. Semin Thromb Hemost 2002;28:S41-8.
2. Lensing AW, Prins MH, Davidson BL. Hirsh J. Treatment of deep venous thrombosis with low-molecular-weight heparins. Arch Intern Med 1995;155:601-7.
3. Follea G, Laville M, Pozet N, Dechavanne M. Pharmacokinetic studies of standard heparin and low molecular weight heparin in patients with chronic renal failure. Haemostasis 1986;16(2):147-51.
4. Goudable C, Saivin S, Houin G, et al. Pharmacokinetics of a low molecular weight heparin (Fraxiparine) in various stages of chronic renal failure. Nephron 1991;59(4):543-5.
5. Farooq V, Hegarty J, Chandrasekar T, et al. Serious adverse incidents with the usage of low molecular weight heparins in patients with chronic kidney disease. Am J Kidney Dis 2004;43:531-7.